age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
32.99899
|
female
| 1
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 19
|
$25-$50k
| 9
| 88,720
| 46,155.375
| null | 39.5
|
other
| 45.195313
| 75
| 0.397949
| 0.200989
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 10
| 62
| 11.599609
| 130
| 8
| 36.59375
| 296.625
| 2
| 31
| 4.199219
| 127
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
72.39697
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 11,588
| 6,508.8789
| null | 6
|
black
| 20.699219
| 29
| 0.830933
| 0.723999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 115
| 6.599609
| 104
| 20
| 37.29688
| 460
| null | null | 2.299805
| 138
| 7.549805
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 26
| 1
|
66.5
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 29,870
| 16,443.3594
| null | 17.5
|
white
| 21.898438
| 29
| 0.834961
| 0.730957
| 1
| 0
| 0
|
no
| 0.25
| 0.75
|
no dnr
| 12
| 85
| 10.898438
| 88
| 16
| 36.39844
| null | null | null | 2.299805
| 133
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 539
| 1
|
72.78296
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
| null | 0
| 45,798
| 26,877.8594
| null | 16.666656
|
white
| 30.398438
| 40
| 0.66394
| 0.48999
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 24
| 65
| 13.5
| 105
| 26
| 39
| 132.5
| 2.899902
| 0.5
| 1.699951
| 139
| 7.519531
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 153
| 1
|
61.56897
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 22,040
| 13,137.5078
| null | 9
|
white
| 11.898438
| 26
| 0.930908
| 0.882935
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 11
| 90
| 6.5
| 80
| 20
| 36
| null | 4.699219
| 1.099854
| 1.699951
| 134
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,958
| 0
|
52.43298
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 0
| 12,161
| 6,753.2773
| null | 7
|
black
| 16.898438
| 10
| 0.839966
| 0.649902
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 3
| 89
| 7.899414
| 46
| 20
| 36.79688
| null | null | 0.399963
| 0.899902
| 140
| null | null | null | null | 2
| 2
|
<2 mo. follow-up
| 2
| 53
| 1
|
66.93195
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 88,469
| 46,006.1562
| null | 18.666656
|
black
| 21.699219
| 55
| 0.755981
| 0.678955
| 4
| 0
| 0
|
yes
| 0.95
| 0.85
|
no dnr
| 17
| 141
| 22.296875
| 148
| 28
| 37.5
| 256.625
| 2.199707
| 0.799927
| 1.099854
| 142
| 7.459961
| null | null | null | null | 2
| null | 2
| 1,955
| 0
|
84.76697
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
|
under $11k
| 0
| 19,608
| 9,826.8906
| null | 14
|
white
| 21.699219
| 44
| 0.718994
| 0.56189
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 8
| 70
| 11.5
| 75
| 50
| 36.5
| 200
| null | null | 0.799927
| 138
| 7.429688
| null | null | null | 1
| 7
|
adl>=4 (>=5 if sur)
| 7
| 128
| 1
|
80.172
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 6,148
| 3,811.3106
| null | 9
|
white
| 17.296875
| 16
| 0.845947
| 0.747925
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 83
| 15.898438
| 85
| 20
| 36
| 462.5
| null | 0.299988
| 1.299805
| 136
| 7.349609
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,730
| 1
|
79.96997
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 17,554
| 10,868.0859
| null | 10
|
other
| 18
| 27
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 69
| 11.199219
| 62
| 20
| 36.5
| 352.375
| null | null | 1.5
| 140
| 7.469727
| null | null | null | 0
| null | null | 0.4948
| 275
| 1
|
66.45599
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 25,668
| 14,813.8359
| null | 17.5
|
white
| 17.296875
| 11
| 0.883911
| 0.806885
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 85
| 4.799805
| 70
| 20
| 36.39844
| null | 3.699707
| 1.199951
| 0.899902
| 129
| null | null | null | null | 0
| 0
| null | 0
| 1,952
| 0
|
58.116
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 33,960
| 16,787.625
| null | 46
|
white
| 37.898438
| 60
| 0.534912
| 0.419983
| 2
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 4
| 66
| 18.898438
| 130
| 30
| 37.69531
| 81.32812
| 2.299805
| 10.5
| 0.799927
| 143
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 2.756348
| 4
| 1
|
67.49097
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 172,597
| 87,621.75
| null | 24.666656
|
white
| 28.898438
| 41
| 0.527954
| 0.412964
| 9
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 24
| 100
| 18.296875
| 102
| 20
| 37.39844
| 156
| 4.799805
| 1.399902
| 5.799805
| 141
| 7.469727
| null | null | null | null | null | null | 2.750977
| 1,951
| 0
|
52.09
|
male
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 13,414
| 8,930.6719
| null | 7.5
|
white
| 21.898438
| 34
| 0.805908
| 0.68689
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 11
| 89
| 6.399414
| 92
| 20
| 37.39844
| 442.8125
| 2.199707
| 10.898438
| 1.199951
| 133
| 7.429688
| null | null | null | 5
| 1
|
<2 mo. follow-up
| 1
| 35
| 1
|
66.59296
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 5,872
| 3,679.9609
| null | 7
|
black
| 13.798828
| 36
| 0.910889
| 0.849976
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 5
| 76
| 6.5
| 84
| 24
| 36.39844
| 533.25
| 3.699707
| 3.399902
| 1.599854
| 139
| 7.479492
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
56.13998
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,083
| 3,908.0156
| null | 11
|
white
| 16.796875
| 20
| 0.850952
| 0.753906
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 109
| 5.399414
| 80
| 20
| 36.59375
| null | 3
| 1.099854
| 1.899902
| 139
| null | null | null | null | null | null | null | 2.0625
| 1,949
| 0
|
63.76199
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 7,737
| 5,288.8438
| null | 5.5
|
white
| 13.699219
| 11
| 0.858887
| 0.684937
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 1
| 104
| 7.799805
| 78
| 22
| 36.59375
| null | null | null | null | 137
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.708008
| 48
| 1
|
39.73199
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 16,616
| 9,458.5
| null | 13
|
black
| 18.5
| 16
| 0.92688
| 0.876953
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 69
| null | 112
| 22
| 37.19531
| null | null | null | 1.399902
| 137
| null | null | null | null | 6
| 4
|
no(M2 and SIP pres)
| 4
| 394
| 1
|
60.40198
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 9,381
| 5,027.7227
| null | 12
|
white
| 12
| 9
| 0.931885
| 0.884888
| 1
| 0
| 0
|
no
| null | 0.75
|
no dnr
| 3
| 80
| 9.099609
| 106
| 18
| 37
| null | 4.299805
| 0.899902
| 1.099854
| 137
| null | null | null | null | 0
| 0
| null | 0
| 1,944
| 0
|
57.771
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 25,187
| 14,744.7969
| null | 6.5
|
other
| 5.5
| 20
| 0.928955
| 0.833984
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 9
| 111
| 9.298828
| 88
| 20
| 38
| null | 4.299805
| 0.899902
| 1.5
| 138
| null | null | null | null | null | null | null | 2.093262
| 1,745
| 1
|
48.07397
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,570
| 3,670.0703
| null | 9
|
other
| 19.097656
| 39
| 0.908936
| 0.846924
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 4
| 69
| 8.199219
| 88
| 28
| 36.39844
| 255
| null | null | 1.699951
| 135
| 7.5
| null | null | null | null | null | null | 2.357422
| 831
| 1
|
76.68396
|
female
| 1
| 58
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 26
| 229,314
| 109,920.375
| null | 29
|
black
| 25.296875
| 27
| 0.532959
| 0.417969
| 3
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 44
| 84
| 24.796875
| 145
| 16
| 38.69531
| 150
| null | 0.299988
| 0.799927
| 138
| 7.509766
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 58
| 1
|
78.35699
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 4,629
| 3,081.2656
| null | 7
|
black
| 21.398438
| 30
| 0.799927
| 0.67688
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 60
| 8.599609
| 115
| 20
| 36
| 404.75
| null | null | 1.5
| 137
| 7.469727
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 374
| 1
|
85.29999
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 20,365
| 10,969.5312
| null | 18
|
white
| 24.296875
| 36
| 0.678955
| 0.584961
| 4
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 1
| 62
| 12.099609
| 64
| 36
| 36.89844
| 142.84375
| 2.599609
| 0.599976
| 1.299805
| 146
| 7.299805
| null | null | null | null | null |
<2 mo. follow-up
| 2.947266
| 4
| 1
|
62.47498
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 68,367
| 36,036.9688
| null | 22.666656
|
white
| 28.398438
| 40
| 0.755981
| 0.61499
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 22
| 55
| 11.298828
| 105
| 24
| 36.69531
| null | 3.299805
| 2.399902
| 1.5
| 125
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 150
| 1
|
76.41296
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
| null | 0
| 4,386
| 2,759.834
| null | 8
|
black
| 21.199219
| 31
| 0.80896
| 0.691895
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 4
| 113
| 3.199707
| 80
| 20
| 36.29688
| null | 3.099609
| 0.799927
| 2.199707
| 144
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.395996
| 449
| 1
|
45.11398
|
male
| 1
| 11
|
Lung Cancer
|
Cancer
| 1
| null | null | 9
| 13,100
| 7,766.0273
| null | 7.5
|
black
| 25.699219
| 11
| 0.518921
| 0.196991
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 109
| 10.798828
| 98
| 18
| 36.39844
| null | 3.199707
| null | 0.599976
| 130
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.758301
| 11
| 1
|
68.12598
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 6,992
| 4,581.8008
| null | 6
|
black
| 17.699219
| 20
| 0.779907
| 0.647949
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 80
| 6.399414
| 80
| 16
| 37.19531
| 485.6875
| 2.5
| 3.399902
| 0.699951
| 133
| 7.459961
| null | null | null | null | null | null | 2.259277
| 460
| 1
|
82.17694
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 0
| 15,942
| 10,364.7812
| null | 13
|
white
| 4.5
| 17
| 0.862915
| 0.69397
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 90
| 17.296875
| 80
| 24
| 37.69531
| null | 4.399414
| 1
| 0.899902
| 140
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 597
| 1
|
41.87
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null |
>$50k
| 0
| 68,108
| 38,119.4688
| null | 23.333328
|
white
| 18.097656
| 17
| 0.875
| 0.792969
| 3
| 0
| 0
|
no
| 0.5
| 0.6
|
no dnr
| 15
| 95
| 18.296875
| 64
| 16
| 36.5
| 235
| null | 2.299805
| 1.099854
| 140
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,935
| 0
|
76.20795
|
female
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 9
| 3,644
| 2,314.8516
| null | 5
|
black
| 21.5
| 29
| 0.611938
| 0.424988
| 1
| 1
| 0
|
no
| 0.2
| 0.008
|
no dnr
| 3
| 103
| 4.799805
| 90
| 20
| 37.69531
| null | null | null | 1.5
| 124
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 23
| 1
|
60.04398
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 37
| 506,141
| 272,995.25
| null | 44
|
white
| 29.398438
| 42
| 0.467957
| 0.348999
| 60
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 11
| 67
| 1.099854
| 82
| 26
| 37.39844
| 228.875
| 4
| 1.399902
| 2.099609
| 131
| 7.399414
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 11
| 1
|
77.13898
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
|
$11-$25k
| 0
| 159,553
| 81,082.1875
| null | 46
|
white
| 28.5
| 45
| 0.580933
| 0.470947
| 17
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 67
| 14.599609
| 94
| 24
| 36.19531
| 156.90625
| null | 1.799805
| 2.5
| 137
| 7.5
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 12
| 1
|
72.96399
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$11-$25k
| 0
| 42,243
| 22,744.0781
| null | 23.5
|
white
| 29
| 26
| 0.625
| 0.521973
| 6
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 56
| 3.899902
| 69
| 20
| 38.5
| 110
| 2.599609
| null | 0.599976
| 135
| 7.349609
| null | null | null | 4
| 3
|
adl>=4 (>=5 if sur)
| 3
| 1,934
| 0
|
59.40598
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 19,852
| 11,541.8047
| null | 17.5
|
white
| 25.199219
| 53
| 0.817993
| 0.704956
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 9
| 57
| 7.599609
| 114
| 28
| 36.5
| null | 4
| 1.099854
| 2.799805
| 135
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 96
| 1
|
72.83795
|
male
| 1
| 109
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 740,010
| 357,918.75
| null | 47.5
|
white
| 29
| 43
| 0.490967
| 0.372986
| 9
| 0
| 0
|
no
| null | null |
dnr after sadm
| 67
| 67
| 11.599609
| 95
| 18
| 38.79688
| 140
| 2.699707
| null | 3.5
| 134
| 7.469727
| null | null | null | null | null |
Coma or Intub
| 2.823731
| 109
| 1
|
50.23099
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 44,480
| 24,166.0312
| null | 19.5
|
white
| 20.5
| 19
| 0.789917
| 0.721924
| 3
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 13
| 94
| 11.898438
| 97
| 38
| 39.19531
| 204.0625
| null | null | 1.099854
| 140
| 7.429688
| null | null | null | null | null | null | 3.461426
| 1,933
| 0
|
71.56195
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 15,051
| 8,141.4531
| null | 9
|
white
| 5.099609
| 14
| 0.920898
| 0.814941
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.5
|
no dnr
| 8
| 137
| 15.398438
| 80
| 20
| 38.5
| null | 4.399414
| null | 0.699951
| 141
| null | null | null | null | 1
| null | null | 1.1669
| 817
| 1
|
71.90399
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 10
| null | 0
| 24,612
| 14,901.6641
| null | 7.5
|
hispanic
| 13.199219
| 20
| 0.851929
| 0.671997
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.857375
|
no dnr
| 9
| 106
| 13.898438
| 88
| 20
| 36
| null | 3.899902
| 0.599976
| 1.299805
| 136
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 385
| 1
|
44.62997
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 40,418
| 20,818.8438
| null | 30
|
white
| 21.597656
| 35
| 0.873901
| 0.829956
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 78
| 28.296875
| 122
| 16
| 38.69531
| 204.4375
| 4.199219
| null | 1
| 140
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.363281
| 6
| 1
|
51.98398
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 29,303
| 16,406.4062
| null | 17
|
white
| 5.199219
| 12
| 0.934937
| 0.845947
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.857375
|
no dnr
| 12
| 95
| 13.898438
| 64
| 18
| 37.5
| 300
| 4.599609
| 1.099854
| 0.599976
| 137
| 7.469727
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 588
| 1
|
53.82599
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
$25-$50k
| 0
| 24,587
| 14,452.7344
| null | 9
|
hispanic
| 22.597656
| 27
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| 0.85
| 0.614125
|
no dnr
| 16
| 63
| 8
| 96
| 18
| 35.89844
| null | null | null | 1.599854
| 129
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.606445
| 26
| 1
|
50.431
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 26
| 70,463
| 35,895.0938
| null | 47
|
white
| 43
| 78
| 0.068985
| 0.024998
| 4
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 6
| 54
| 12.699219
| 136
| 32
| 36.89844
| 175
| null | 7.799805
| 2.699707
| 132
| 7.189453
| null | null | null | null | null |
<2 mo. follow-up
| 3.104492
| 6
| 1
|
31.69099
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 274,531
| 165,149
| null | 26.75
|
hispanic
| 34.09375
| 43
| 0.725952
| 0.641968
| 6
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 28
| 140
| 13.398438
| 50
| 28
| 38.89844
| 167.5
| 3.899902
| 27.5
| 0.899902
| 137
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,167
| 1
|
65.30896
|
female
| 0
| 25
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 26
| 84,901
| 40,449.3125
| null | 16
|
white
| 21.898438
| 18
| 0.779907
| 0.647949
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 25
| 99
| 14.599609
| 150
| 16
| 37.39844
| 348.5625
| null | null | 0.699951
| 136
| 7.469727
| null | null | null | null | null |
SIP>=30
| 3.000977
| 866
| 1
|
81.54095
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 20,850
| 13,284.5781
| null | 10
|
white
| 28.5
| 27
| 0.580933
| 0.387939
| 1
| 0
| 1
|
yes
| 0.25
| 0.1
|
no dnr
| 15
| 84
| 65
| 61
| 20
| 37.19531
| 359.25
| 2.299805
| null | 1.799805
| 139
| 7.449219
| null | null | null | null | 6
| null | 6
| 91
| 1
|
66.39795
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
|
under $11k
| 0
| 17,247
| 10,426.7891
| null | 20
|
white
| 15.099609
| 35
| 0.901978
| 0.835938
| 1
| 0
| 0
|
no
| null | 0.7
|
no dnr
| 6
| 59
| 6.099609
| 54
| 18
| 36.59375
| 376.1875
| 4.199219
| null | 1.5
| 134
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 106
| 1
|
50.20099
|
male
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 218,924
| 100,290
| null | 33.75
|
white
| 37.5
| 63
| 0.518921
| 0.402954
| 13
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 16
| 60
| 3.899902
| 145
| 27
| 37.69531
| 122.5
| null | 0.5
| 3.399902
| 134
| 7.229492
| null | null | null | null | null |
<2 mo. follow-up
| 2.536621
| 34
| 1
|
88.29797
|
male
| 0
| 29
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 63,639
| 39,865.0938
| null | 13.25
|
white
| 24.5
| 41
| 0.677979
| 0.506958
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 29
| 72
| 11.199219
| 80
| 26
| 37.19531
| 180
| null | null | 2
| 131
| 7.479492
| null | null | null | null | 2
| null | 2
| 623
| 1
|
58.41498
|
female
| 0
| 23
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 58,940
| 26,872.9688
| null | 19.666656
|
white
| 13.798828
| 11
| 0.86499
| 0.697998
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 23
| 91
| 5.099609
| 88
| 24
| 37
| null | null | 1
| 1
| 138
| null | null | null | null | null | null | null | 2.505859
| 217
| 1
|
56.34998
|
female
| 0
| 15
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 26,731
| 13,389.5703
| null | 14.333328
|
white
| 22.597656
| 39
| 0.606934
| 0.290955
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 7
| 67
| 7.599609
| 140
| 36
| 39
| 216.65625
| null | null | 0.799927
| 135
| 7.459961
| null | null | null | null | null | null | 3.6875
| 74
| 1
|
71.69897
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 0
| 19
| null | 0
| 5,319
| 3,470.7637
| null | 8
|
white
| 17.097656
| 18
| 0.802979
| 0.579956
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 68
| 5.299805
| 60
| 20
| 37
| null | 3.299805
| 0.599976
| 0.899902
| 143
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,922
| 0
|
32.13998
|
male
| 1
| 27
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 256,835
| 123,820.938
| null | 33.25
|
other
| 55.195313
| 63
| 0.006
| 0.001
| 12
| 0
| 0
|
yes
| 0.1
| 0.001
|
no dnr
| 27
| 24
| 20.199219
| 145
| 30
| 38.69531
| 222.5
| null | 1
| 2.199707
| 125
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.214844
| 27
| 1
|
48.10999
|
female
| 0
| 26
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 2
|
$11-$25k
| 0
| 56,562
| 31,515.375
| null | 16.75
|
hispanic
| 27.796875
| 42
| 0.733887
| 0.583984
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
no dnr
| 26
| 77
| 4.799805
| 92
| 30
| 36.19531
| null | null | 17.796875
| 1
| 131
| null | null | null | null | 3
| 0
|
<2 mo. follow-up
| 0
| 41
| 1
|
76.383
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 24,788
| 14,783.8203
| null | 15.5
|
other
| 6
| 16
| 0.909912
| 0.791992
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 11
| 82
| 5.5
| 62
| 18
| 37
| 390.4375
| 4.299805
| 0.5
| 1
| 134
| 7.389648
| null | null | null | null | null | null | 2.262207
| 1,921
| 0
|
57.81
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 125,797
| 58,915.1875
| null | 30
|
white
| 24.898438
| 36
| 0.747925
| 0.668945
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
dnr after sadm
| 8
| 113
| 20.597656
| 82
| 16
| 37
| 267.5
| null | 4.399414
| 2.699707
| 144
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
66.76794
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 15,358
| 9,215.3125
| null | 9.5
|
white
| 14.398438
| 22
| 0.846924
| 0.661987
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 79
| 3.299805
| 87
| 19
| 36.5
| null | null | 0.5
| 1.299805
| 139
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 657
| 1
|
46.45898
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 21,906
| 12,927.0312
| null | 10
|
white
| 4
| 9
| 0.94397
| 0.86792
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 7
| 89
| 9.699219
| 80
| 20
| 37.5
| null | 4.299805
| 0.199982
| 1.099854
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 414
| 1
|
64.34796
|
female
| 0
| 20
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 77,328
| 42,579.8125
| null | 16
|
white
| 13.298828
| 25
| 0.861938
| 0.691895
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 20
| 120
| 11.099609
| 112
| 28
| 38.79688
| null | 2.699707
| 0.699951
| 0.799927
| 138
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 451
| 1
|
75.23596
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 26,189
| 14,225.7031
| null | 19.5
|
asian
| 5.099609
| 22
| 0.917969
| 0.80896
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 12
| 103
| 10.298828
| 90
| 20
| 37
| 628
| 4.399414
| 0.5
| 1.299805
| 137
| 7.289062
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 539
| 1
|
74.60394
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
| null | 0
| 58,853
| 31,826.5625
| null | 19.666656
|
white
| 25.097656
| 41
| 0.697998
| 0.606934
| 7
| 0
| 1
|
no
| 0.7
| 0.6
|
no dnr
| 14
| 157
| 14.699219
| 40
| 16
| 36
| 220
| null | 0.599976
| 1.799805
| 136
| 7.359375
| null | null | null | null | null | null | 4.647461
| 1,691
| 1
|
36.45999
|
female
| 0
| 33
|
Coma
|
Coma
| 0
| null | null | 61
| 201,322
| 112,886.875
| null | 30.75
|
white
| 30.398438
| 36
| 0.438965
| 0.365967
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 33
| 110
| 16
| 123
| 34
| 39
| 104
| 5.699219
| null | 0.699951
| 139
| 7.5
| null | null | null | null | null | null | 2.36377
| 1,913
| 0
|
63.77298
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 26
| 89,043
| 47,001
| null | 24
|
white
| 28.398438
| 24
| 0.54895
| 0.434998
| 15
| 0
| 1
|
no
| 0.5
| 0.15
|
dnr after sadm
| 17
| 71
| 11.599609
| 96
| 32
| 38
| 128.5625
| 3.599609
| 0.5
| 0.799927
| 127
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 4.415039
| 21
| 1
|
65.70599
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 18
|
$25-$50k
| 0
| 8,729
| 4,916.8086
| null | 9.5
|
hispanic
| 17.398438
| 20
| 0.809937
| 0.593994
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 84
| 10.5
| 81
| 20
| 37.89844
| null | null | 5
| 1.199951
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 140
| 1
|
20.83199
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 392,950
| 197,040.125
| null | 37
|
white
| 88.390625
| 106
| 0
| 0
| 63
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 0
| 5.799805
| 0
| 0
| 37.79688
| 130
| 4
| 10.5
| 3.599609
| 132
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 1.141602
| 3
| 1
|
52.668
|
female
| 1
| 13
|
Coma
|
Coma
| 0
| null | null | 94
| 104,602
| 52,896.7812
| null | 37
|
white
| 19.097656
| 6
| 0.422974
| 0.349976
| 6
| 0
| 0
|
no
| null | null | null | null | 88
| 14.898438
| 72
| 12
| 36.19531
| 277.5
| null | null | 0.5
| 138
| 7.579102
| null | null | null | null | null |
<2 mo. follow-up
| 2.500977
| 13
| 1
|
75.36798
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 125,256
| 64,887.8125
| null | 35
|
white
| 30.097656
| 73
| 0.44696
| 0.326965
| 8
| 1
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 13
| 63
| 12.898438
| 60
| 4
| 37.79688
| 166
| null | 1.099854
| 8.599609
| 132
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.930664
| 13
| 1
|
53.86697
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 18
| null | 0
| 20,923
| 12,116.0312
| null | 6
|
white
| 14.199219
| 25
| 0.92395
| 0.871948
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 63
| 6.5
| 68
| 26
| 36
| 400
| 3.899902
| 0.099991
| 1.299805
| 139
| 7.459961
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,909
| 0
|
44.35898
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 12,042
| 6,767.7578
| null | 12
|
white
| 21.796875
| 35
| 0.895996
| 0.825928
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 69
| 9.5
| 136
| 20
| 36.39844
| 261.875
| null | 0.5
| 1.599854
| 137
| 7.419922
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.432617
| 543
| 1
|
53.62097
|
female
| 0
| 34
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 279,530
| 180,716.375
| null | 21.75
|
white
| 17.898438
| 21
| 0.848999
| 0.751953
| 1
| 0
| 0
|
no
| 0.65
| 0.4
|
no dnr
| 34
| 76
| 6.5
| 88
| 18
| 37.19531
| null | 2.199707
| 1.5
| 1.099854
| 128
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.432129
| 58
| 1
|
84.90295
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 15
|
$11-$25k
| 0
| 9,291
| 5,748.9297
| null | 3.5
|
white
| 21
| 21
| 0.705933
| 0.422974
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 7
| 86
| 4.799805
| 80
| 20
| 36.29688
| null | 3.099609
| 0.699951
| 1.699951
| 141
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,227
| 1
|
70.83899
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,955
| 6,502.7344
| null | 11
|
white
| 25.199219
| 46
| 0.771973
| 0.636963
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 2
| 68
| 10
| 61
| 39
| 37.09375
| 383.625
| null | null | 3.299805
| 133
| 7.579102
| null | null | null | null | null |
<2 mo. follow-up
| 4.18457
| 24
| 1
|
70.06195
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 15,687
| 10,228.8594
| null | 11
|
hispanic
| 24
| 43
| 0.793945
| 0.668945
| 1
| 1
| 0
|
no
| 0.85
| 0.7
|
no dnr
| 11
| 111
| 7.399414
| 80
| 16
| 35.89844
| 304.75
| 3.199707
| 1.399902
| 2.699707
| 134
| 7.479492
| null | null | null | 0
| 1
|
SIP>=30
| 1
| 266
| 1
|
37.71899
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
| null | 26
| 268,805
| 132,976.5
| null | 48
|
white
| 37.59375
| 78
| 0.442993
| 0.323975
| 48
| 0
| 0
|
no
| 0.1
| 0.001
| null | null | 61
| 0.099991
| 140
| 45
| 39.09375
| 238
| null | 0.799927
| 2.799805
| 148
| 7.429688
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
65.45697
|
female
| 1
| 19
|
Lung Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 41,397
| 23,832
| null | 12
|
black
| 14.398438
| 21
| 0.754883
| 0.497986
| 1
| 0
| 0
|
metastatic
| 0.45
| 0.2
|
dnr after sadm
| 17
| 90
| 18.898438
| 68
| 18
| 36.19531
| 285.6875
| 3.799805
| 0.699951
| 1
| 134
| 7.459961
| null | null | null | 0
| 5
|
<2 mo. follow-up
| 5
| 19
| 1
|
29.88399
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 26
| 223,581
| 103,008.562
| null | 28.75
|
white
| 34
| 30
| 0.550903
| 0.437988
| 9
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr after sadm
| 33
| 81
| 10.599609
| 118
| 20
| 38
| 95
| 2.599609
| 6
| 0.599976
| 135
| 7.389648
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 34
| 1
|
87.521
|
female
| 0
| 90
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 469,824
| 232,752.25
| null | 32.25
|
white
| 30.199219
| 54
| 0.47699
| 0.357971
| 12
| 0
| 0
|
no
| null | null |
no dnr
| 90
| 127
| 15.5
| 120
| 34
| 37.79688
| 75
| 2.099609
| 0.099991
| 1.199951
| 134
| 7.469727
| null | null | null | null | null | null | 3.319336
| 1,530
| 1
|
18.146
|
male
| 0
| 85
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 26
| 641,888
| 328,378.5
| null | 43.25
|
hispanic
| 40.195313
| 87
| 0.625977
| 0.522949
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 85
| 44
| 2
| 142
| 27
| 37.19531
| 314.25
| 1.899902
| 0.299988
| 10.699219
| 134
| 7.349609
| null | null | null | null | 0
|
Coma or Intub
| 0
| 1,899
| 0
|
42.92398
|
male
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 277,421
| 133,680.875
| null | 33
|
white
| 36.796875
| 70
| 0.426941
| 0.307983
| 54
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 63
| 32.59375
| 132
| 50
| 39.5
| 77.32812
| 2.099609
| null | 1.5
| 135
| 7.209961
| null | null | null | null | null |
<2 mo. follow-up
| 3.061035
| 20
| 1
|
37.396
|
female
| 1
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$11-$25k
| 0
| 166,927
| 86,323.875
| null | 43.666657
|
black
| 26.5
| 51
| 0.730957
| 0.577881
| 5
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 16
| 73
| 5.899414
| 120
| 24
| 37.09375
| 233.3125
| null | null | 3.199707
| 132
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.849121
| 17
| 1
|
63.46899
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 29,732
| 16,300.9844
| null | 16.5
|
white
| 7.299805
| 23
| 0.912964
| 0.79895
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 12
| 124
| 5.399414
| 118
| 20
| 37.39844
| 313.3125
| 4.699219
| 0.799927
| 0.799927
| 133
| 7.419922
| null | null | null | null | null | null | 2.17627
| 1,023
| 1
|
53.57999
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 5,132
| 2,881.541
| null | 9
|
white
| 17.398438
| 31
| 0.92395
| 0.870972
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 93
| 12.398438
| 92
| 12
| 36.59375
| 256
| null | 0.299988
| 1.099854
| 136
| 7.519531
| null | null | null | null | null | null | 2.358398
| 1,572
| 1
|
70.07495
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
|
$11-$25k
| 0
| 33,290
| 18,993.5312
| null | 12.333328
|
black
| 16.199219
| 22
| 0.884888
| 0.807983
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 20
| 80
| null | 90
| 18
| 36.79688
| null | 4.099609
| null | 2
| 132
| null | null | null | null | 0
| 1
| null | 1
| 324
| 1
|
47.633
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 138,674
| 71,315.3125
| null | 15
|
asian
| 70.09375
| 83
| 0
| 0
| 21
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 25
| 4.5
| 125
| 10
| 36
| 167.34375
| null | 32.398438
| 3.599609
| 142
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 1.694092
| 3
| 1
|
51.54797
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 170,244
| 79,871.5
| null | 24
|
white
| 28.898438
| 32
| 0.659912
| 0.56189
| 10
| 0
| 0
|
yes
| 0.25
| 0.015625
|
no dnr
| 37
| 65
| 17.597656
| 126
| 29
| 37.89844
| 165
| null | null | 0.599976
| 132
| 7.469727
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 466
| 1
|
90.83899
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 14,065
| 8,867.6719
| null | 8.333328
|
white
| 17.296875
| 28
| 0.80896
| 0.690918
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 100
| 10.898438
| 82
| 22
| 36.19531
| 210
| null | null | 1
| 145
| 7.519531
| null | null | null | null | null | null | 3.875977
| 708
| 1
|
35.625
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 23,421
| 12,434.3672
| null | 39
|
black
| 50.296875
| 80
| 0.356995
| 0.23999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 25
| 19.796875
| 150
| 28
| 37.19531
| 309.5
| null | null | 2.5
| 135
| 7.15918
| null | null | null | null | null |
<2 mo. follow-up
| 2.098633
| 3
| 1
|
63.85999
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| null | null | 94
| 47,424
| 25,078.2031
| null | 15
|
white
| 20.296875
| 22
| 0.280945
| 0.211975
| 5
| 0
| 0
|
no
| null | null | null | null | 139
| 8.298828
| 122
| 10
| 38.69531
| 350
| null | null | 0.699951
| 149
| 7.529297
| null | null | null | null | null |
<2 mo. follow-up
| 2.530762
| 5
| 1
|
67.04199
|
male
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 9
| 100,735
| 55,332.7812
| null | 13
|
white
| 20
| 35
| 0.790894
| 0.7229
| 7
| 0
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 31
| 129
| 9.398438
| 125
| 36
| 38
| 272.5
| 3.199707
| null | 1
| 138
| 7.489258
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,216
| 1
|
61.16098
|
female
| 0
| 106
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 970,982
| 39.496
| null | 38.25
|
white
| 30.597656
| 56
| 0.571899
| 0.460999
| 29
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 106
| 66
| 14.699219
| 105
| 20
| 36.5
| 274
| 3.199707
| 6.099609
| 2.599609
| 134
| 7.40918
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.803711
| 1,889
| 0
|
77.13098
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 29,403
| 5,321.5938
| null | 17
|
white
| 16.597656
| 33
| 0.687988
| 0.395996
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 62
| 5.599609
| 82
| 12
| 36.39844
| 276.1875
| null | null | 1.199951
| 135
| 7.429688
| null | null | null | null | null | null | 2.981445
| 465
| 1
|
19.14
|
male
| 0
| 56
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 216,359
| 134,573.25
| null | 15.75
|
white
| 20.597656
| 21
| 0.944946
| 0.905884
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 56
| 61
| 8.5
| 108
| 26
| 36.5
| null | 4.299805
| 1.099854
| 0.899902
| 125
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,889
| 0
|
64.18097
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 2
| 14
|
$11-$25k
| 0
| 26,311
| 13,976.2734
| null | 16.5
|
white
| 11.199219
| 21
| 0.881958
| 0.73291
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 11
| 100
| 9.298828
| 120
| 18
| 37.5
| null | 4.299805
| 1.099854
| 0.799927
| 133
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 683
| 1
|
53.30298
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 17,823
| 8,599.2031
| null | 10.5
|
white
| 20.5
| 12
| 0.789917
| 0.556885
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.9
|
no dnr
| 9
| 89
| 10.199219
| 120
| 20
| 39.69531
| null | null | 0.399963
| 0.699951
| 138
| null | null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 1,887
| 0
|
55.28799
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 19,419
| 11,965.4844
| null | 13
|
white
| 24.699219
| 38
| 0.799927
| 0.677979
| 1
| 0
| 0
|
yes
| 0.8
| 0.2
|
no dnr
| 9
| 59
| 5.799805
| 145
| 20
| 37
| 456.625
| 2.899902
| 0.799927
| 0.899902
| 133
| 7.369141
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.123047
| 91
| 1
|
53.14697
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 16,552
| 9,827.4219
| null | 20
|
asian
| 10.5
| 23
| 0.948975
| 0.911987
| 1
| 0
| 0
|
no
| 0.8
| 0.4
|
no dnr
| 6
| 75
| 6.699219
| 72
| 18
| 36.09375
| null | 4.699219
| 2.799805
| 1.099854
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,162
| 1
|
32.44098
|
male
| 0
| 281
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 37
| 1,273,347
| 633,212
| null | 38.5
|
white
| 32.296875
| 44
| 0.569946
| 0.458984
| 58
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 281
| 51
| 16.699219
| 96
| 30
| 37.39844
| 108.5625
| 2.399902
| 1
| 0.699951
| 143
| 7.509766
| null | null | null | null | 7
|
Coma or Intub
| 7
| 386
| 1
|
58.95999
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 9
| 207,902
| 121,042.438
| null | 23
|
white
| 23.398438
| 17
| 0.748901
| 0.669922
| 19
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 26
| 115
| 6.199219
| 132
| 20
| 39.79688
| 326.625
| null | null | 0.599976
| 136
| 7.5
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,882
| 0
|
27.411
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 122,322
| 63,008.5625
| null | 18.5
|
white
| 22
| 40
| 0.879883
| 0.837891
| 1
| 0
| 0
|
no
| 0.5
| 0.8
|
no dnr
| 27
| 78
| 27.597656
| 130
| 8
| 38.5
| 228
| 2.599609
| 1.599854
| 0.699951
| 137
| 7.529297
| null | null | null | 0
| 1
| null | 1
| 1,881
| 0
|
77.09497
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 9
| 23,862
| 13,112.5312
| null | 17.5
|
white
| 22.097656
| 30
| 0.768921
| 0.631958
| 1
| 1
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 9
| 93
| 11.599609
| 86
| 22
| 36.59375
| null | null | null | 3.399902
| 137
| null | null | null | null | 3
| 0
| null | 0
| 248
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.